Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Commentaries
You have accessRestricted Access

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2

Charles A. Herzog
CJASN November 2016, 11 (11) 2095-2096; DOI: https://doi.org/10.2215/CJN.09470916
Charles A. Herzog
Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota; and Division of Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 11 no. 11 2095-2096
DOI 
https://doi.org/10.2215/CJN.09470916
PubMed 
27797902

Published By 
American Society of Nephrology
Print ISSN 
1555-9041
Online ISSN 
1555-905X
History 
  • Published online November 7, 2016.

Article Versions

  • Earlier version (October 25, 2016 - 04:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by the American Society of Nephrology

Author Information

  1. Charles A. Herzog
  1. Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota; and Division of Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota
  1. Correspondence:
    Dr. Charles A. Herzog, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South Eighth Street, Suite S4.100, Minneapolis, MN 55404. Email: cherzog{at}cdrg.org

Statistics from Altmetric.com

Article usage

Article usage: October 2016 to December 2020

AbstractFullPdf
Oct 20160183107
Nov 20160146208
Dec 2016021395
Jan 201703250
Feb 201702440
Mar 2017014530
Apr 201701620
May 201701924
Jun 2017076
Jul 201702314
Aug 201701423
Sep 201701613
Oct 201701217
Nov 201708235
Dec 201704031
Jan 201804315
Feb 201804512
Mar 201803913
Apr 201805914
May 201805315
Jun 201804716
Jul 201804510
Aug 201804010
Sep 201803911
Oct 201804114
Nov 201803411
Dec 201803513
Jan 201903512
Feb 201903513
Mar 201901810
Apr 20190278
May 201905816
Jun 201904310
Jul 201903115
Aug 201904120
Sep 201903111
Oct 20190279
Nov 201902414
Dec 20190199
Jan 20200259
Feb 20200216
Mar 202001712
Apr 20200154
May 20200138
Jun 20200164
Jul 20200229
Aug 2020087
Sep 20200298
Oct 202004712
Nov 202001612
Dec 20200276

Cited By...

  • 2 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 11 (11)
Clinical Journal of the American Society of Nephrology
Vol. 11, Issue 11
November 07, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Charles A. Herzog
CJASN Nov 2016, 11 (11) 2095-2096; DOI: 10.2215/CJN.09470916

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Charles A. Herzog
CJASN Nov 2016, 11 (11) 2095-2096; DOI: 10.2215/CJN.09470916
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 3
  • Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
Show more Commentaries

Cited By...

  • Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Keywords

  • atrial fibrillation
  • end-stage renal disease
  • Anticoagulants
  • blood coagulation
  • Disease Management
  • Humans
  • Kidney Failure, Chronic

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire